|
RAD17 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.71589999999888E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.980250E-03 |
| Normal-vs-Stage2 |
5.362400E-02 |
| Normal-vs-Stage3 |
2.78139999920768E-08 |
| Normal-vs-Stage4 |
1.42490000021311E-07 |
| Stage1-vs-Stage2 |
8.752200E-01 |
| Stage1-vs-Stage3 |
8.376200E-04 |
| Stage1-vs-Stage4 |
2.721000E-03 |
| Stage2-vs-Stage3 |
3.800200E-02 |
| Stage2-vs-Stage4 |
3.956400E-02 |
| Stage3-vs-Stage4 |
9.288800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.57050000000525E-05 |
| Normal-vs-AfricanAmerican |
2.192900E-04 |
| Normal-vs-Asian |
8.520400E-03 |
| Caucasian-vs-AfricanAmerican |
6.761800E-01 |
| Caucasian-vs-Asian |
3.320000E-01 |
| AfricanAmerican-vs-Asian |
3.566000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.61919999999805E-06 |
| Normal-vs-Female |
7.018600E-04 |
| Male-vs-Female |
1.788970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.71829949847347E-10 |
| Normal-vs-Age(41-60Yrs) |
1.66943999999614E-05 |
| Normal-vs-Age(61-80Yrs) |
7.812700E-04 |
| Normal-vs-Age(81-100Yrs) |
2.677600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.995500E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.90909999999711E-05 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.346040E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.511360E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.782400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.511800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.108100E-02 |
| Normal-vs-Grade 2 |
2.188100E-02 |
| Normal-vs-Grade 3 |
5.7957999999303E-07 |
| Normal-vs-Grade 4 |
1.56700208364668E-11 |
| Grade 1-vs-Grade 2 |
9.165400E-01 |
| Grade 1-vs-Grade 3 |
2.520100E-02 |
| Grade 1-vs-Grade 4 |
5.58789999999254E-05 |
| Grade 2-vs-Grade 3 |
1.378360E-03 |
| Grade 2-vs-Grade 4 |
7.3493999774854E-09 |
| Grade 3-vs-Grade 4 |
1.996100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.965200E-01 |
| Normal-vs-ccB subtype |
2.66398014758806E-12 |
| ccA subtype-vs-ccB subtype |
1.63924429585904E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.351300E-04 |
| Normal-vs-N1 |
1.991520E-04 |
| N0-vs-N1 |
1.261400E-01 |
|
|
